Abstract
Background: Renal transplantation is the treatment of choice for chronic kidney disease (CKD) patients, but the shortage of kidneys and the disabling medical conditions these patients suffer from make dialysis essential for most of them. Since dialysis drastically affects the patients’ lifestyle, there are great expectations for the development of wearable artificial kidneys, although their use is currently impeded by major concerns about safety. On the other hand, dialysis patients with hemodynamic instability do not usually tolerate intermittent dialysis therapy because of their inability to adapt to a changing scenario of unforeseen events. Thus, the development of novel wearable dialysis devices and the improvement of clinical tolerance will need contributions from new branches of engineering such as artificial intelligence (AI) and machine learning (ML) for the real-time analysis of equipment alarms, dialysis parameters, and patient-related data with a real-time feedback response. These technologies are endowed with abilities normally associated with human intelligence such as learning, problem solving, human speech understanding, or planning and decision-making. Examples of common applications of AI are visual perception (computer vision), speech recognition, and language translation. In this review, we discuss recent progresses in the area of dialysis and challenges for the use of AI in the development of artificial kidneys. Summary and Key Messages: Emerging technologies derived from AI, ML, electronics, and robotics will offer great opportunities for dialysis therapy, but much innovation is needed before we achieve a smart dialysis machine able to analyze and understand changes in patient homeostasis and to respond appropriately in real time. Great efforts are being made in the fields of tissue engineering and regenerative medicine to provide alternative cell-based approaches for the treatment of renal failure, including bioartificial renal systems and the implantation of bioengineered kidney constructs.
References
1.
Sharma
K
, Rupprecht
C
, Caroli
A
, Aparicio
MC
, Remuzzi
A
, Baust
M
, et al. Automatic Segmentation of Kidneys using Deep Learning for Total Kidney Volume Quantification in Autosomal Dominant Polycystic Kidney Disease
. Sci Rep
. 2017
May
;7
(1
):2049
.
[PubMed]
2045-23222.
Akl
AI
, Sobh
MA
, Enab
YM
, Tattersall
J
. Artificial intelligence: a new approach for prescription and monitoring of hemodialysis therapy
. Am J Kidney Dis
. 2001
Dec
;38
(6
):1277
–83
.
[PubMed]
0272-63863.
Barbieri
C
, Molina
M
, Ponce
P
, Tothova
M
, Cattinelli
I
, Ion Titapiccolo
J
, et al. An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients
. Kidney Int
. 2016
Aug
;90
(2
):422
–9
.
[PubMed]
0085-25384.
Choi
JW
, Lee
H
, Lee
JC
, Lee
S
, Kim
YS
, Yoon
HJ
, et al. Application of genetic algorithm for hemodialysis schedule optimization
. Comput Methods Programs Biomed
. 2017
Jul
;145
:35
–43
.
[PubMed]
0169-26075.
Chris O’Connor: Managing Engineering Complexity: Are you ready? Available from: https://www.ibm.com/blog/internet-of-things/iot-managing-engeenering-complexity/
6.
Waqaas Al-Siddiq
. The impact of Artificial Intelligence on Medtech.
Available from: https://www.mpo-mag.com/contents/view_online-exclusives/2017-04-07/the-impact-of-artificial-intelligence-on-medtec7.
Santoro
A
, Mancini
E
, Basile
C
, Amoroso
L
, Di Giulio
S
, Usberti
M
, et al. Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial
. Kidney Int
. 2002
Sep
;62
(3
):1034
–45
.
[PubMed]
0085-25388.
Clark
WR
, Neri
M
, Garzotto
F
, Ricci
Z
, Goldstein
SL
, Ding
X
, et al. The future of critical care: renal support in 2027
. Crit Care
. 2017
Apr
;21
(1
):92
.
[PubMed]
1364-85359.
Bagshaw
SM
, Chakravarthi
MR
, Ricci
Z
, Tolwani
A
, Neri
M
, De Rosa
S
, et al.; ADQI Consensus Group
. Precision Continuous Renal Replacement Therapy and Solute Control
. Blood Purif
. 2016
;42
(3
):238
–47
.
[PubMed]
0253-506810.
Cerdá
J
, Baldwin
I
, Honore
PM
, Villa
G
, Kellum
JA
, Ronco
C
; ADQI Consensus Group
. Role of Technology for the Management of AKI in Critically Ill Patients: From Adoptive Technology to Precision Continuous Renal Replacement Therapy
. Blood Purif
. 2016
;42
(3
):248
–65
.
[PubMed]
0253-506811.
Mehta
RL
, Cerdá
J
, Burdmann
EA
, Tonelli
M
, García-García
G
, Jha
V
, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
. Lancet
. 2015
Jun
;385
(9987
):2616
–43
.
[PubMed]
0140-673612.
Li
P
, Qu
LP
, Qi
D
, Shen
B
, Wang
YM
, Xu
JR
, et al. High-dose versus low-dose haemofiltration for the treatment of critically ill patients with acute kidney injury: an updated systematic review and meta-analysis
. BMJ Open
. 2017
Oct
;7
(10
):e014171
.
[PubMed]
2044-605513.
Curthoys
NP
, Moe
OW
. Proximal tubule function and response to acidosis
. Clin J Am Soc Nephrol
. 2014
Sep
;9
(9
):1627
–38
.
[PubMed]
1555-904114.
Humes
HD
, Buffington
D
, Westover
AJ
, Roy
S
, Fissell
WH
. The bioartificial kidney: current status and future promise
. Pediatr Nephrol
. 2014
Mar
;29
(3
):343
–51
.
[PubMed]
0931-041X15.
Song
JH
, Humes
HD
. The bioartificial kidney in the treatment of acute kidney injury
. Curr Drug Targets
. 2009
Dec
;10
(12
):1227
–34
.
[PubMed]
1389-450116.
Humes
HD
, Sobota
JT
, Ding
F
, Song
JH
, Group
RI
; RAD Investigator Group
. A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure
. Blood Purif
. 2010
;29
(2
):183
–90
.
[PubMed]
0253-506817.
Pino
CJ
, Yevzlin
AS
, Tumlin
J
, Humes
HD
. Cell-based strategies for the treatment of kidney dysfunction: a review
. Blood Purif
. 2012
;34
(2
):117
–23
.
[PubMed]
0253-506818.
Brian Blum
. Saving Lives in the ICU through artificial intelligence.
Available from: https://www.Israel21c.org19.
Davoudi
A
, Malhotra
KR
, Shickel
B
, Siegel
S
, Williams
S
, Ruppert
M
, et al. The Intelligent ICU Pilot Study: Using Artificial Intelligence Technology for Autonomous Patient Monitoring. arXiv:1804.10201 2018
.20.
Powles
J
, Hodson
H
. Google DeepMind and healthcare in an age of algorithms
. Health Technol (Berl)
. 2017
;7
(4
):351
–67
.
[PubMed]
2190-718821.
Shah
H
. The DeepMind debacle demands dialogue on data
. Nature
. 2017
Jul
;547
(7663
):259
.
[PubMed]
0028-083622.
Wing
JM
. Computational thinking and thinking about computing. Philos Trans A Math Phys
. Eng Sci
. 1881
;2008
(366
):3717
–25
.0013-781223.
Laura Pappano
. Learning to think like a computer.
The New York Times. April 4, 2017
. Available from: https://www.nytimes.com/2017/04/04/education/edlife/teaching-students-computer-code.html24.
Chung
HC
, Ko
IK
, Atala
A
, Yoo
JJ
. Cell-based therapy for kidney disease
. Korean J Urol
. 2015
Jun
;56
(6
):412
–21
.
[PubMed]
2005-673725.
Li
Z
, Araoka
T
, Wu
J
, Liao
HK
, Li
M
, Lazo
M
, et al. 3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic Progenitors
. Cell Stem Cell
. 2016
Oct
;19
(4
):516
–29
.
[PubMed]
1934-590926.
Bantounas
I
, Ranjzad
P
, Tengku
F
, Silajdžić
E
, Forster
D
, Asselin
MC
, et al. Generation of Functioning Nephrons by Implanting Human Pluripotent Stem Cell-Derived Kidney Progenitors
. Stem Cell Reports
. 2018
Mar
;10
(3
):766
–79
.
[PubMed]
2213-671127.
Montserrat
N
, Garreta
E
, Izpisua Belmonte
JC
. Regenerative strategies for kidney engineering
. FEBS J
. 2016
Sep
;283
(18
):3303
–24
.
[PubMed]
1742-464X28.
Orlando
G
, Farney
AC
, Iskandar
SS
, Mirmalek-Sani
SH
, Sullivan
DC
, Moran
E
, et al. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations
. Ann Surg
. 2012
Aug
;256
(2
):363
–70
.
[PubMed]
0003-493229.
Derakhshanfar
S
, Mbeleck
R
, Xu
K
, Zhang
X
, Zhong
W
, Xing
M
. 3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances
. Bioact Mater
. 2018
Feb
;3
(2
):144
–56
.
[PubMed]
2452-199X30.
Kim
S
, Fissell
WH
, Humes
DH
, Roy
S
. Current strategies and challenges in engineering a bioartificial kidney
. Front Biosci (Elite Ed)
. 2015
Jan
;7
(2
):215
–28
.
[PubMed]
1945-049431.
Kensinger
C
, Karp
S
, Kant
R
, Chui
BW
, Goldman
K
, Yeager
T
, et al. First Implantation of Silicon Nanopore Membrane Hemofilters
. ASAIO J
. 2016
Jul-Aug
;62
(4
):491
–5
.
[PubMed]
1058-291632.
Buck
AK
, Goebel
SG
, Goodin
MS
, Wright
NJ
, Groszek
JJ
, Moyer
J
, et al. Original article submission: platelet stress accumulation analysis to predict thrombogenicity of an artificial kidney
. J Biomech
. 2018
Mar
;69
:26
–33
.
[PubMed]
0021-929033.
Gura
V
, Rivara
MB
, Bieber
S
, Munshi
R
, Smith
NC
, Linke
L
, et al. A wearable artificial kidney for patients with end-stage renal disease
. JCI Insight
. 2016
Jun
;1
(8
):e86397
.
[PubMed]
2379-370834.
Hueso
M
, Vellido
A
, Montero
N
, Barbieri
C
, Ramos
R
, Angoso
M
, et al. Artificial Intelligence for the Artificial Kidney: Pointers to the Future of a Personalized Hemodialysis Therapy
. Kidney Dis (Basel)
. 2018
Feb
;4
(1
):1
–9
.
[PubMed]
2296-938135.
Venuthurupalli
SK
, Hoy
WE
, Healy
HG
, Cameron
A
, Fassett
RG
. CKD Screening and Surveillance in Australia: Past, Present, and Future
. Kidney Int Rep
. 2017
Oct
;3
(1
):36
–46
.
[PubMed]
2468-024936.
Som
A
, Groenendyk
J
, An
T
, Patel
K
, Peters
R
, Polites
G
, et al. Improving Dialysis Adherence for High Risk Patients Using Automated Messaging: proof of Concept
. Sci Rep
. 2017
Jun
;7
(1
):4177
.
[PubMed]
2045-232237.
Iori
F
, Grechy
L
, Corbett
RW
, Gedroyc
W
, Duncan
N
, Caro
CG
, Vincent
PE
. The effect of in-plane arterial curvature on blood flow and oxygen transport in arterio-venous fistulae.
Phys Fluids (1994) 2015
, 27 (3), 031903. 38.
Chanliau
J
, Charasse
C
, Rose
C
, Béné
B
. Clinical evaluation of an expert system for arteriovenous fistula assessment
. Int J Artif Organs
. 2014
Nov
;37
(11
):809
–15
.
[PubMed]
0391-398840.
41.
Rachel
Z
. Arndt. Is Facebook making moves in healthcare? Available from: http://www.modernhealthcare.com/article/20180427/NEWS/180429912© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
